Endocrine Abstracts

Introduction: Follicular thyroid carcinoma (FTC) is the second most common thyroid tumor and accounts for about 5-10 % of all thyroid cancers. As FTC often retains the ability to concentrate radioactive iodine (I131), tumor may be responsive to I131 therapy. However, about 60-70 % of all metastatic thyroid cancers are resistant to I131 and has a poor prognosis with 10-year survival rate of 10 % and the average life expectancy 3-5 years after di...